Semaglutide (Ozempic, Wegovy, Rybelsus): A specific type of GLP-1 receptor agonist that has a 94% similarity to human GLP-1 but is designed to last much longer in the body, requiring less frequent dosing
They even offer a free doctor chat to get you started, and the pricing is clear
Impact on Growth in Children: For children who are still growing, a reduced appetite can lead to slowed weight gain or, in some cases, a temporary reduction in growth rates
Clinical trial data shows approximately 25-30% of weight lost consists of lean mass (including muscle) without specific interventions
The enhanced circulation and muscle-building properties it provides also translate into healthier joints
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship